Sfoglia per AUTORE
BRIA E
Collezione AO Cuneo

  

Items : 8

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial. in Scientific reports / Sci Rep. 2021 Jul 2;11(1):13770. doi: 10.1038/s41598-021-92774-z.

2021
AO Cuneo

Vici P; Ciliberto G; Sanguineti G; Di Leo A; De Maria R; Daralioti T; Sperduti I; Perracchio L; di Benedetto A; Del Medico P; Roselli M; Vaccaro A; Garufi C; Cazzaniga M; Lorusso V; Russo A; Pistelli M; Giotta F; Meattini I; Garrone O; Paris I; Sarobba G; Veltri E; Corsi D; D'Ostilio N; Grassadonia A; Valerio MR; Mirabelli R; Fabbri MA; et alii...

Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO). in La Radiologia medica / Radiol Med. 2021 Aug;126(8):1117-1128. doi: 10.1007/s11547-021-01362-8. Epub 2021 May 5.

2021
AO Cuneo

Arcangeli S; Ricardi U; Bria E; D'Angelillo RM; Pappagallo GL; Lohr F; Chiari R; Scotti V; Trovò M; Ramella S; Bruni A; Borghetti P; Merlotti A;

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. in Journal of cellular physiology / J Cell Physiol. 2020 Nov;235(11):7900-7910. doi: 10.1002/jcp.29445. Epub 2020 Jan 15.

2020
AO Cuneo

Vici P; Giordano A; Barba M; Mazzotta M; Sperduti I; Ciliberto G; Villa A; Risi E; De Maria R; Del Medico P; Generali D; Meattini I; Livi L; Garrone O; Baldini E; Zamagni C; Pistelli M; Cannita K; Valerio MR; Berardi R; Russo A; Ricciardi G; Adamo V; Ficorella C; Roselli M; Lorusso V; Landucci E; Paris I; Giotta F; et alii...

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2020 Dec 10;39(1):279. doi: 10.1186/s13046-020-01797-3.

2020
AO Cuneo

Roselli M; Del Medico P; Cazzaniga M; Garufi C; Sarobba G; Giotta F; Paris I; Garrone O; Veltri E; Corsi D; D'Ostilio N; Fabbri MA; Russo A; Mirabelli R; Valerio MR; Marchetti P; Tomao S; Marinelli D; Mazzotta M; Barchiesi G; Zamagni C; Tonini G; Adamo V; Michelotti A; Moscetti L; Bria E; Cassano A; La Verde N; Generali D; et alii...

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. in International journal of cancer / Int J Cancer. 2020 Apr 1;146(7):1917-1929. doi: 10.1002/ijc.32583. Epub 2019 Aug 7.

2020
AO Cuneo

Vici P; Di Leo A; Barba M; Villa A; Ciliberto G; Sperduti I; De Maria R; Risi E; Generali D; De Tursi M; Sarobba G; Del Medico P; Meattini I; Desideri I; Livi L; Baldini E; Di Cocco B; Foglietta J; Greco F; Zamagni C; Garrone O; D'Ostilio N; Sini V; Cannita K; Adamo V; Ricciardi GRR; Fiorio E; Pistelli M; Russo A; et alii...

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Aug;134:210-217. doi: 10.1016/j.lungcan.2019.06.028. Epub 2019 Jun 27.

2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Novello S; Migliaretti G; Pacchiana MV; Stura I; Critelli R; Metro G; Morelli AM; Manzo A; Ricciardi S; Bria E; Colantonio I; Ciuffreda L; Pisconti S; Ceresoli GL; Del Conte A; Gregorc V; Scotti V; Galetta D; Romano G; Grossi F; Delmonte A; Costanzo FD; Tiseo M; Chiari R; Morabito A; Capelletto E; Migliorino MR;

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer. in PloS one / PLoS One. 2015 Sep 4;10(9):e0136731. doi: 10.1371/journal.pone.0136731. eCollection 2015.

2015
ASL Cuneo 1
AO Cuneo
AOU Novara

Mentuccia L; Laudadio L; Zoboli A; Marchetti F; Bogina G; Lunardi G; Boni L; Gamucci T; Evangelisti L; Barni S; Saracchini S; Amaducci L; Santini D; Fabi A; Garrone O; Frassoldati A; Cavanna L; Saggia C; Bria E; Cretella E; Vici P; Spazzapan S; Iezzi L; De Simone V; Duranti S; Cavazzini MG; Turazza M; Gubiotti M; Foglietta J; et alii...

International tailored chemotherapy adjuvant trial: Itaca trial in Journal of Clinical Oncology

2012
AO Cuneo

Novello S; Manegold C; Grohe C; Colantonio I; Serke MH; Geissler M; Valmadre G; Schuette W; Stoelben E; Bria E; Monica V; Torri V; Scagliotti G;